Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romain Casey

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Multiple Sclerosis and Related Disorders|May 14, 2026
External validation and improvement of an algorithm that identifies multiple sclerosis relapses in the French national healthcare claims databaseLaure Carcaillon-Bentata, Abdelilah Abouelfath, Séverine Lignot-Maleyran, et al.
Neurology|September 25, 2024
Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis: A Multicenter Real-Life StudyMarion Hay, Fabien Rollot, Romain Casey, et al.
JAMA Neurology|September 4, 2019
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in FranceSandra Vukusic, Fabien Rollot, Romain Casey, et al.
Neurology|July 30, 2025
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple SclerosisAntoine Gavoille, Emmanuelle Leray, Romain Marignier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2022
Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring systemCamille Sabathé, Romain Casey, Sandra Vukusic, et al.
JAMA Neurology|August 4, 2025
Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple SclerosisAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 4, 2025
Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosisAntoine Gavoille, Mikail Nourredine, Fabien Rollot, et al.
European Journal of Neurology|May 2, 2025
Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM studyMikael Cohen, Fabien Rollot, Marc Debouverie, et al.
Neurology|July 14, 2019
Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosisDavid-Axel Laplaud, Romain Casey, Laetitia Barbin, et al.
Neurology|December 23, 2022
Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal InferenceAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Multiple Sclerosis and Related Disorders|May 14, 2026
External validation and improvement of an algorithm that identifies multiple sclerosis relapses in the French national healthcare claims databaseLaure Carcaillon-Bentata, Abdelilah Abouelfath, Séverine Lignot-Maleyran, et al.
Neurology|September 25, 2024
Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis: A Multicenter Real-Life StudyMarion Hay, Fabien Rollot, Romain Casey, et al.
JAMA Neurology|September 4, 2019
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in FranceSandra Vukusic, Fabien Rollot, Romain Casey, et al.
Neurology|July 30, 2025
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple SclerosisAntoine Gavoille, Emmanuelle Leray, Romain Marignier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2022
Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring systemCamille Sabathé, Romain Casey, Sandra Vukusic, et al.
JAMA Neurology|August 4, 2025
Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple SclerosisAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 4, 2025
Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosisAntoine Gavoille, Mikail Nourredine, Fabien Rollot, et al.
European Journal of Neurology|May 2, 2025
Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM studyMikael Cohen, Fabien Rollot, Marc Debouverie, et al.
Neurology|July 14, 2019
Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosisDavid-Axel Laplaud, Romain Casey, Laetitia Barbin, et al.
Neurology|December 23, 2022
Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal InferenceAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
Pageof 7